HSDD Guidance on the Agenda at The Menopause Society’s 2026 Meeting

A preview of the October 24 HSDD session, with separate clinical context on discussing overlapping pain and low desire without assuming a diagnosis.

HSDD Guidance on the Agenda at The Menopause Society’s 2026 Meeting
Share
White Reddit alien mascot face icon on transparent background.White paper airplane icon on transparent background.White stylized X logo on black background, representing the brand X/Twitter.
Oct 24, 2026
Sexual Wellbeing & Intimate Confidence

On October 20, 2026, Contemporary OB/GYN previewed The Menopause Society’s 2026 Annual Meeting and an October 24 sexual-health session on applying updated guidance for hypoactive sexual desire disorder (HSDD). The scheduled session concerns guidance from the International Society for the Study of Women’s Sexual Health (ISSWSH).

An application update

This announcement concerns applying guidance in clinical care. It is not a documented shift from an older medical consensus to a newly established standard.

The preview does not identify a previous standard being replaced or reproduce the guidance and its evidence base. It omits the session’s title and speakers along with its time and specific recommendations. It supplies neither diagnostic criteria nor a treatment plan and reports no patient outcomes.

For women reading the coverage, the useful distinction is between professional education and a personal care decision. A session about applying guidance is relevant to the quality of clinical discussion. It is not a reason to attach a diagnosis to a change in desire before that experience has been heard.

The strongest reader-facing context comes from separate clinical coverage about listening carefully when pain and low desire occur together.

On the agenda

  • Applying updated HSDD guidance. Contemporary OB/GYN says the October 24 sexual-health session will address application of updated ISSWSH guidance. The emphasis in the preview is on use in practice. For readers, that makes the session worth following as clinician education rather than treating the announcement itself as a new set of instructions for managing desire.
  • A wider menopause meeting. The annual meeting was scheduled for October 20 to 24 at the Hilton Bayfront in San Diego, California. A separate Medscape listing confirms the dates and San Diego location. Contemporary OB/GYN reported that more than 2,000 health care professionals were expected and in-person registration had sold out. Those details describe the meeting’s scale rather than evidence about a clinical approach.
  • Other subjects have separate coverage. The preview also lists sleep disorders and mood disorders within the wider program. Chronic pelvic pain and midlife lifestyle topics appear there too. Their inclusion should not be read as a description of the HSDD session or as confirmation that its guidance addresses each subject. A conference program brings different topics together without making them one clinical explanation.
  • Pain and desire deserve careful listening. In separate Contemporary OB/GYN coverage, Sheryl Kingsberg, PhD, discussed a case involving genitourinary syndrome of menopause (GSM) and HSDD. The report described pain and low desire occurring together and potentially influencing one another. This is related clinical context from a different case and event, not a report of what the October 24 session will teach.

Hear the account

In that separate report, Kingsberg’s central point was about the way a conversation begins. Open-ended questions can help a clinician understand what is troubling a patient rather than assuming which symptom is driving her distress. Follow-up questions can then clarify whether pain or low desire is present, or whether both need attention.

The distinction is practical. A woman may bring a concern about desire into an appointment while also having pain to describe. The reported case illustrates why those experiences should be heard together without automatically treating one as the explanation for the other.

This does not require the reader to arrive with a polished clinical account. The starting point is her experience: what feels different and what she finds troubling. The clinician’s role in the discussion described by Kingsberg is to ask further questions rather than let an initial label stand in for that account.

For readers trying to name what has changed, separating desire from physical discomfort is a useful distinction. Separating the terms does not mean separating the person into unrelated problems. It means giving each concern enough space to be understood before deciding how they fit together.

The editorial lesson is not that every sexual concern needs a longer list of possible diagnoses. It is that the first description should remain open to clarification. A question about desire deserves an answer that reflects what the woman is actually describing.

Start with experience

For a woman concerned about desire, the practical implication supported by Kingsberg’s discussion is straightforward: begin with what feels different or distressing. There is no need to turn the meeting announcement into a personal checklist. A description of the concern gives the clinician something to ask about.

If pain is part of the experience, mention it explicitly. In the reported case, pain and desire concerns occurred together. Leaving either out would leave part of that account unheard.

Useful subjects for that conversation include:

  • The change that matters to you. Describe the part of your experience that feels different rather than beginning with an assumed explanation.
  • Any pain alongside the concern. Give discomfort its own place in the discussion instead of expecting the clinician to infer it from a statement about desire.
  • What is most troubling. Explain which concern you want help understanding so the conversation reflects your priorities.
  • Questions that remain unresolved. Ask the clinician to clarify how the concerns may relate rather than deciding in advance that one must explain the other.

These are conversation prompts drawn from the report’s emphasis on open-ended discussion. They are not assessment criteria. Decisions about diagnosis or treatment belong with a qualified clinician who can address the individual situation.

Kingsberg’s reported approach also supports shared decision-making. That means the woman’s account has a role beyond opening the appointment: it helps clarify what the discussion is trying to address. The name of a condition should serve that understanding rather than replace it.

There is room here for direct language without having to sound medical. Saying that desire feels different communicates one concern. Saying that pain is also present communicates another. The clinical conversation can then examine the relationship between them instead of requiring the woman to settle that question herself.

Keep priorities personal

Refemina’s view is that intimate comfort and sexual confidence are legitimate parts of health. They do not need to be sensationalised to deserve attention. Nor should a professional meeting announcement create a new expectation that women must measure themselves against a preferred level of desire.

The relevant question for the reader is not whether her experience resembles a conference topic. It is whether there is something she wants help understanding. That keeps the focus on the concern she brings rather than on the prominence of a diagnostic term in a headline.

This is a place for a broader view of midlife desire, not a judgement about how a woman ought to feel. The separate case report offers a concrete reason for that editorial approach: pain and desire concerns can coexist, while open-ended discussion can help clarify what matters to the patient.

A useful way to follow the meeting coverage is therefore to look for how clinical application is explained. The meaningful question is how guidance helps a clinician move from hearing a concern to understanding it. Attention to that process is more useful than assuming that the word updated means every woman’s experience now has a different explanation.

The clinical direction

For clinical practice, the promise of this session is clearer application of HSDD guidance that keeps a woman’s own account of desire and pain central to assessment.

How Refemina helps

Low desire can become a clinical headline before a woman’s questions about intimacy have been heard. Refemina’s editorial approach puts those questions alongside the quality of the evidence, helping readers make sense of desire and comfort while treating sexual confidence as a valid part of midlife health rather than a problem with a ready-made solution.

Explore Resources

Sources

  1. TMS 2026
  2. Why open-ended questions matter when GSM and HSDD overlap | Contemporary OB/GYN

Continue reading

October 28, 2026
Nutrition & Weight Management

Menopause Weight Management: Meals, Muscle and the Evidence

read article
October 28, 2026
Skin, Hair & Aesthetic Aging

Facial Hair in Menopause: Match the Method to the Goal

read article
October 28, 2026
Perimenopause, Menopause & Hormonal Change

Night Sweats in Midlife: The Signs That Call for a Broader Review

read article
YOUR NEXT CHAPTER

Feel informed, strong and at home in your changing body

Keep learning about the changes that shape energy, strength, confidence and wellbeing through midlife.

Explore Resources